Literature DB >> 20435520

The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture.

Ana Martín1, Marta Herranz, María Jesús Ruiz Serrano, Emilio Bouza, Darío García de Viedma.   

Abstract

BACKGROUND: The application of molecular tools has revealed that infection by Mycobacterium tuberculosis (MTB) is more complex than initially assumed. Genotyping is generally performed on cultures. However, there is no information about bacterial clonal complexity in clinical specimens or whether standard culture procedures can modify this complexity.
METHODS: An in vitro assay was performed to determine whether culture can modify the clonal complexity of the MTB population in clinical specimens. Pairs of MTB strains (10 pairs) or stain-positive sputa (4 pairs) were mixed in different volumetric proportions. The DNA extracted from the mixtures before and after culture was genotyped using mycobacterial interspersed repetitive unit-variable-number tandem repeat analysis to detect potential changes in the proportion of the mixed strains.
RESULTS: In 6/10 pairs of MTB strains and 2/4 pairs of sputa, marked changes were observed in clonal composition after culture, even in mixtures of strains differing in their drug-susceptibility patterns. In some cases, only one of the mixed strains was detected after culture.
CONCLUSIONS: The initial clonal composition in bacteriologically complex clinical specimens could be underestimated if genotyping analysis is performed after culture. Genotyping strategies aimed at analyzing clinical samples must be optimized to reveal the real dimension of clonal complexity in infection by MTB. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435520     DOI: 10.1016/j.tube.2010.03.012

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  24 in total

1.  Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa.

Authors:  Ted Cohen; Douglas Wilson; Kristina Wallengren; Elizabeth Y Samuel; Megan Murray
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

2.  Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved.

Authors:  Yurena Navarro; Marta Herranz; Laura Pérez-Lago; Miguel Martínez Lirola; Maria Jesús Ruiz-Serrano; Emilio Bouza; Darío García de Viedma
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

3.  Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests.

Authors:  Nicola M Zetola; Chawangwa Modongo; Patrick K Moonan; Ronald Ncube; Keikantse Matlhagela; Enoch Sepako; Ronald G Collman; Gregory P Bisson
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

4.  Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.

Authors:  Nicola M Zetola; Sanghyuk S Shin; Kefentse A Tumedi; Keletso Moeti; Ronald Ncube; Mark Nicol; Ronald G Collman; Jeffrey D Klausner; Chawangwa Modongo
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

Review 5.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

6.  Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi.

Authors:  Kim Mallard; Ruth McNerney; Amelia C Crampin; Rein Houben; Richard Ndlovu; Lumbani Munthali; Robin M Warren; Neil French; Judith R Glynn
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

7.  Clonal Complexity in Mycobacterium tuberculosis Can Hamper Diagnostic Procedures.

Authors:  Laura Pérez-Lago; Marta Herranz; Yurena Navarro; María Jesús Ruiz Serrano; Pilar Miralles; Emilio Bouza; Darío García-de-Viedma
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

Review 8.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance.

Authors:  Sanghyuk S Shin; Chawangwa Modongo; Yeonsoo Baik; Christopher Allender; Darrin Lemmer; Rebecca E Colman; David M Engelthaler; Robin M Warren; Nicola M Zetola
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

10.  Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.

Authors:  Suzanne M Hingley-Wilson; Rosalyn Casey; David Connell; Samuel Bremang; Jason T Evans; Peter M Hawkey; Grace E Smith; Annette Jepson; Stuart Philip; Onn Min Kon; Ajit Lalvani
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.